Evidence map›Paper›PMID 41031710›Full record

ArticleJournal of occupational health2025

Work productivity by diseases diagnosed among workers: a study using large-scale claims data and survey data of workers in Japan.

Takuya Maekawa, Kentaro Yamato, Norihiro Nakamichi, Yuka Kurita, Masami Nakai, Chihiro Osawa, Akiko Hatakama, Hitoshi Suzuki, Masaya Takahashi, Ryotaro Ishii and 1 more

Abstract read
In one paragraph

Article in Journal of occupational health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Takuya MaekawaMedical Affairs, Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan.ORCID 0009-0005-1540-9831
Kentaro YamatoMedical Affairs, Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan.
Norihiro NakamichiMedical Affairs, Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan.
Yuka KuritaMedical Affairs, Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan.
Masami NakaiMedical Affairs, Otsuka Pharmaceutical Co, Ltd, Osaka, Japan.
Chihiro OsawaMedical Affairs, Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan.
Akiko HatakamaIndustry Management Division, DeSC Healthcare Inc, Tokyo, Japan.
Hitoshi SuzukiIndustry Management Division, DeSC Healthcare Inc, Tokyo, Japan.
Masaya TakahashiResearch Center for Overwork-Related Disorders, National Institute of Occupational Safety and Health, Kawasaki, Japan.
Ryotaro IshiiDepartment of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Takeo NakayamaDepartment of Health Informatics, Graduate School of Medicine and School of Public Health, Kyoto University, Kyoto, Japan.

Funding

Otsuka Pharmaceutical Co, Ltd (Tokyo, Japan)
6 · The paper itself

Abstract

objectivesJapan faces the need for occupational health management based on an understanding of workers' health and its impact on work productivity. Given a paucity of comprehensive studies, we conducted this study to investigate work productivity by diseases among workers of various occupations in Japan, by using a large-scale database.

methodsThis retrospective, descriptive study used pre-existing data derived from health insurance claims and 2 surveys conducted in 2021. The analysis included the data of ≥19-year-old current workers with response data to the questions regarding Work Productivity and Activity Impairment (WPAI). The WPAI of the target diseases, defined by claims diagnosis codes, was plotted against the 1-year prevalence of each disease. The cost of lost productivity was estimated based on the response data regarding the WPAI.

resultsOverall, 31 540 individuals participated, and the analysis showed that psychiatric disorders, headache, epilepsy, and insomnia had a high percentage of participants reporting any level of WPAI, although the prevalence of these diseases was low. We also explored the cost of lost productivity to supplement the interpretation of the overall impact of health problems; however, no clear trend was observed.

conclusionsMany Japanese workers with psychiatric disorders, headaches, epilepsy, and insomnia have impaired work productivity and daily activities.

Indexed as

EfficiencyAdultCost of IllnessFemaleHumansInsurance Claim ReviewJapanMaleMental DisordersMiddle AgedOccupational HealthPrevalenceRetrospective StudiesSleep Initiation and Maintenance DisordersSurveys and QuestionnairesYoung Adultburden of diseasedatabasediseaseJapanproductivity

Identifiers

PMID41031710
PMCPMC12574326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.